Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S. Grasso, Antoni Ribas, Phuong Tran et al.|Cancer Cell|2020Cited by 379
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanomaAnusha Kalbasi, Antoni Ribas|Science Translational Medicine|2020Cited by 129
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 115
Expanding the cytokine receptor alphabet reprograms T cells into diverse statesYang Zhao, K. Christopher García, Masato Ogishi et al.|Nature|2025Cited by 14
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 2